Filter:
The Alpha-1 Foundation convened the third Virtual Alpha-1 Lobby Day on Wednesday, November 10, 2021 during the annual Alpha-1 Awareness […]
November is finally here and with its arrival comes cooler temperatures, autumn scenery, and most importantly, Alpha-1 Awareness Month! On […]
November 1, 2021- The Alpha-1 Foundation Virtual Walk 2021 kicks off today and is off an amazing start! With over […]
Read More… from Grab your sneakers… it’s time for the Alpha-1 Virtual Walk 2021!
For Immediate Release: October 20, 2021 Today, the U.S. Food and Drug Administration took action to expand the use of […]
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a […]
Read More… from CDC Expands Eligibility for COVID-19 Booster Shots
“The Alpha-1 Foundation strongly agrees with the American Thoracic Society (ATS) position objecting to the FDA’s authorization of the tobacco-flavored […]
“The update shared this week by Inhibrx on their Recombinant Alpha-1-antitrypsin (INBRX-101) is exciting news for the Alpha-1 Community. The […]
Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for […]
Read More… from CSL Behring announcement on their product Zemaira
FOR IMMEDIATE RELEASE The Alpha-1 Foundation announces the selection of Mr. Scott Santarella as the new President and Chief Executive […]
Read More… from The Alpha-1 Foundation selects new President and Chief Executive Officer
Through the eyes of Joe Reidy, Alpha and Participant for 25 years: First Autumn Escape to the Cape Bike Trek […]
September 22, 2021- Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 […]
“We are pleased to hear that the Pfizer-BioNTech COVID-19 Vaccine has received full FDA approval. We strongly recommend that everyone receive […]
A company that profits from the sale of tobacco products that cause COPD should not profit from the sale of […]
Read More… from COPD Foundation Condemns Big Tobacco Acquisition of Pharmaceutical Company
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and […]
The HealthCare.gov Special Enrollment Period is coming to an end on August 15, 2021. The Centers for Medicare and Medicaid Services (CMS) […]
Read More… from HealthCare.gov Special Enrollment Period Enrollment Ends August 15!
Glen A. Perkins, 80, of Wildwood, FL passed away peacefully on July 24 at home. Glen will be remembered fondly […]
June 30, 2021 The Honorable Alejandro Mayorkas Secretary U.S. Department of Homeland Security RE: Concerns regarding donation of source plasma […]
Read More… from Alpha-1 Foundation Signs on to APLUS Plasma Collection Concerns Letter
FOR IMMEDIATE RELEASE: The Alpha-1 Foundation has established priorities that are important to its mission of proceeding as rapidly as […]
NPR ARTICLE: June 15, 2021 A small new study offers a glimmer of hope that giving organ transplant recipients a […]
Read More… from A 3rd Dose Of COVID Vaccines May Boost Immunity For Transplant Recipients
The Alpha-1 Foundation is proud to announce and introduce its newest Board of Director, Faron Schonfeld. Faron spent 18 years […]
Read More… from Alpha-1 Foundation welcomes new Board of Director, Faron Schonfeld
Thank you for being part of the 2021 Virtual Alpha-1 National Conference! You, the Alphas, are the center of everything […]
Read More… from Day 3 Recap: Virtual Alpha-1 National Conference
Thank you for participating in DAY TWO of the 2021 Virtual Alpha-1 National Conference. Today was a great day of interaction, […]
Read More… from DAY TWO RECAP: 2021 Virtual Alpha-1 National Conference
Thank you for registering and joining the first day of the 2021 Virtual Alpha-1 National Conference. Today we were joined […]
Read More… from DAY ONE RECAP: 2021 Virtual Alpha-1 National Conference
June 11, 2021 “The Alpha-1 Foundation looks forward to continuing to work with Vertex in their drive to develop primary […]
